Content Block Tag: NRG-LU003

‘Text/HTML’ of page ‘NRG-LU003’

    About This Study   NRG-LU003 is a National Cancer Institute and NRG Oncology clinical trial studying how well a combination of different biomarker/ALK inhibitors work in treating patients with late stage ALK positive non-small cell lung cancer. At this time, it is unknown whether or not a combination of biomarker/ALK inhibitors or chemotherapy […]

‘Text/HTML’ of page ‘NRG-LU003’

‘Text/HTML’ of page ‘NRG-LU003’

                          About NRG Oncology   At NRG Oncology, we focus on conducting clinical studies aimed to improve current cancer care practices and the lives of cancer patients.  NRG Oncology partners with more than 1,300 member sites world-wide to research ways to improve treatment standards in […]

‘Text/HTML’ of page ‘NRG-LU003’

Share this page:

‘Text/HTML’ of page ‘NRG-LU003’

Share this page:

‘Text/HTML’ of page ‘NRG-LU003’